Assessment of the psychometric properties of an english version of the cancer dyspnea scale in people with advanced lung cancer

Autor: Uronis, HE, Shelby, RA, Currow, DC, Ahmedzai, SH, Bosworth, HB, Coan, A, Abernethy, AP

Context: Dyspnea is a poorly understood subjective sensation. Existing dyspnea measures fail to adequately address its multidimensionality. A Japanese group developed and validated the Cancer Dyspnea Scale (CDS) for assessing dyspnea in patients with

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______363::f5991a2c016309001a8ad4486710821e
https://hdl.handle.net/10453/115509

DKN-01 in Combination With Tislelizumab and Chemotherapy as First-Line Therapy in Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: DisTinGuish.

Autor: Klempner SJ; Department of Medicine, Division of Hematology-Oncology, Massachusetts General Hospital, Boston, MA., Sonbol MB; Mayo Clinic, Phoenix, AZ., Wainberg ZA; University of California Los Angeles Medical Center, Los Angeles, CA., Uronis HE; Duke University Medical Center, Durham, NC., Chiu VK; The Angeles Clinic & Research Institute, a Cedars-Sinai affiliate, Los Angeles, CA., Scott AJ; University of Arizona Cancer Center, Tucson, AZ., Iqbal S; University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, CA., Tejani MA; AdventHealth Cancer Institute, Orlando, FL., Chung V; City of Hope National Medical Center, Duarte, CA., Stilian MC; Leap Therapeutics, Inc, Cambridge, MA., Thoma M; Leap Therapeutics, Inc, Cambridge, MA., Zhang Y; Leap Therapeutics, Inc, Cambridge, MA., Kagey MH; Leap Therapeutics, Inc, Cambridge, MA., Baum J; Leap Therapeutics, Inc, Cambridge, MA., Sirard CA; Leap Therapeutics, Inc, Cambridge, MA., Altura RA; Leap Therapeutics, Inc, Cambridge, MA., Ajani JA; MD Anderson Cancer Center, Houston, TX.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Oct 21, pp. JCO2400410. Date of Electronic Publication: 2024 Oct 21.

Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/ Gastroesophageal Adenocarcinoma.

Autor: Catenacci DV, Kang YK, Uronis HE, Lee KW, Ng MC, Enzinger PC, Park SH, Gold PJ, Lacy J, Hochster HS, Oh SC, Kim YH, Marrone KA, Kelly RJ, Juergens RA, Kim JG, Alcindor T, Sym SJ, Song EK, Chee CE, Chao Y, Kim S, Oh DY, Yen J, Odegaard JI, Lagow E, Li D, Sun J, Kaminker P, Moore PA, Rosales MK, Park H

Publikováno v: Oncology (Williston Park, N.Y.) [Oncology (Williston Park)] 2023 Apr 25; Vol. 37 (4), pp. 176-183.

CT-derived body composition measurements as predictors for neoadjuvant treatment tolerance and survival in gastroesophageal adenocarcinoma.

Autor: DeFreitas MR; Department of Radiology, Duke University Medical Center, 2301 Erwin Road, Box 3808, Durham, NC, 27710, USA., Toronka A; Department of Radiology, Duke University Medical Center, 2301 Erwin Road, Box 3808, Durham, NC, 27710, USA., Nedrud MA; Department of Radiology, Duke University Medical Center, 2301 Erwin Road, Box 3808, Durham, NC, 27710, USA., Cubberley S; Department of Radiology, Duke University Medical Center, 2301 Erwin Road, Box 3808, Durham, NC, 27710, USA., Zaki IH; Department of Radiology, Duke University Medical Center, 2301 Erwin Road, Box 3808, Durham, NC, 27710, USA., Konkel B; Department of Radiology, Duke University Medical Center, 2301 Erwin Road, Box 3808, Durham, NC, 27710, USA., Uronis HE; Department of Medicine, Medical Oncology Division, Duke University School of Medicine, Durham, NC, USA., Palta M; Department of Radiation Oncology, Duke University School of Medicine, Durham, NC, USA., Blazer DG; Department of Surgery, Duke University School of Medicine, Durham, NC, USA., Lafata KJ; Department of Radiology, Duke University Medical Center, 2301 Erwin Road, Box 3808, Durham, NC, 27710, USA.; Department of Radiation Oncology, Duke University School of Medicine, Durham, NC, USA.; Electrical and Computer Engineering, Duke University, Durham, NC, USA., Bashir MR; Department of Radiology, Duke University Medical Center, 2301 Erwin Road, Box 3808, Durham, NC, 27710, USA. mustafa.bashir@duke.edu.; Department of Medicine, Medical Oncology Division, Duke University School of Medicine, Durham, NC, USA. mustafa.bashir@duke.edu.

Publikováno v: Abdominal radiology (New York) [Abdom Radiol (NY)] 2023 Jan; Vol. 48 (1), pp. 211-219. Date of Electronic Publication: 2022 Oct 09.

Virtual reality for improving pain and pain-related symptoms in patients with advanced stage colorectal cancer: A pilot trial to test feasibility and acceptability.

Autor: Kelleher SA; Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC., Fisher HM; Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC., Winger JG; Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC., Miller SN; Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC., Amaden GH; Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC., Somers TJ; Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC., Colloca L; Department of Pain and Translational Symptom Science, School of Nursing and Department of Anesthesiology School of Medicine, University of Maryland, Baltimore, MD., Uronis HE; Department of Internal Medicine, Duke University Medical Center, Duke Cancer Institute, Durham, NC., Keefe FJ; Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC.

Publikováno v: Palliative & supportive care [Palliat Support Care] 2022 Aug; Vol. 20 (4), pp. 471-481.